ETON vs HAL · rev $39.0M vs P/E 9.3, $19.05B cap
Eton Pharmaceuticals Inc (ETON) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Eton Pharmaceuticals Inc (ETON) is a drug manufacturers - specialty & generic company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported ETON revenue for 2024-12-31 was $39.0M. Net income was -$3.8M. Revenue was up 23.3% from 2023-12-31 to 2024-12-31. ETON currently screens at market cap $797.9M.
HAL does not have a complete income-statement cache yet.
ETON currently screens at market cap $797.9M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the ETON and HAL stock pages for the full models.
Not investment advice.